𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Platelet-activating factor, eicosanoids, and bradykinin as targets for adjuvant therapies for sepsis

✍ Scribed by Mitchell P Fink

Book ID
117833165
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
111 KB
Volume
12
Category
Article
ISSN
1045-1870

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The human platelet as a reproducible and
The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor
✍ Janice Ekholm; Yoshio Tatsumi; Teri Nouchi; Donald J. Hanahan πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 675 KB

A new procedure for the preparation of human platelets consistently sensitive to platelet-activating factor (PAF) in the low nanomolar range has been developed. Key to the success of this approach was the addition of adenosine during the isolation phase, providing an excellent recovery of stable cel

Platelet-derived growth factor receptor
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
✍ Tadahiko Kubo; Sajida Piperdi; Jeremy Rosenblum; Cristina R. Antonescu; Wen Chen πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 474 KB πŸ‘ 2 views

## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of platelet‐derived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom